6th Oct 2016 13:14
(ShareCast News) - Smith & Nephew's shares fell on Thursday as Berenberg downgraded the stock to 'hold' from 'buy' and cut the target price to 13.40p from 14.85p. "Smith & Nephew has gradually de-emphasised its slower growth areas and implemented various cost-savings measures, reinvesting the procee
Read more31st Aug 2016 16:34
(ShareCast News) - Halma: Jefferies reiterates buy with a target price of 1210p. G4S: UBS maintains buy with a 260p target. Bunzl: Barclays reiterates equal-weight with a 2450p target. Carclo: Finncap reiterates hold with a 150p target. Associated British Foods: Berenberg downgrades to hold with
Read more10th Aug 2016 10:15
(ShareCast News) - Barclays downgraded Smith & Nephew to an 'equalweight' rating from 'overweight' because of recent disappointing results, risks from competitors and likely delays to earnings-enhancing initiatives. Although it upped its price target very slightly to 1,240p from 1,230p, Barclays sai
Read more9th Aug 2016 12:46
(ShareCast News) - Smith&Nephew offers investors exposure to good market positions, especially in the emergng markets space, and a way to tap into the company´s successful acquistion track record, The Times´s Tempus says. To take note of, the business is always facing one headwind or another - be it
Read more8th Aug 2016 07:23
(ShareCast News) - Global medical technology business Smith & Nephew announced on Monday that it has completed the divestiture of its gynaecology business to Medtronic, for $350m. The FTSE 100 firm said the sale of its gynaecology business demonstrates its "disciplined strategic approach" to capital
Read more28th Jul 2016 16:42
(ShareCast News) - FTSE indices were mixed heading towards the closing bell on Thursday, with the blue-chip index helped south by oil stocks undermined by crude's weakness and Royal Dutch Shell's second-quarter shocker. "An unsurprisingly indecisive session in Europe has seen the likes of the FTSE l
Read more28th Jul 2016 08:35
(ShareCast News) - Interim profits at medical technology firm Smith & Nephew were hit by currency headwinds, the company said on Thursday. Pre-tax profits for the period fell to $453m from $481m while trading profits were lower at $483m compared with $512m a year ago. Group revenue for the first ha
Read more11th Jul 2016 13:56
(ShareCast News) - Burberry chief executive Christopher Bailey has been replaced in the role after less than three years by Marco Gobbetti, currently boss of LVMH's Céline luxury brand, as the Yorkshireman steps back to focus solely on the role of chief creative officer. The FTSE 100 fashion house a
Read more18th May 2016 13:25
(ShareCast News) - Smith & Nephew has agreed to sell its gynaecology business for $350m to New York-based Medtronic, of which $300m will be returned to shareholder via a share buyback. The London- and New York-listed medical technology business said the proceeds were surplus to its current capital r
Read more9th May 2016 15:26
(ShareCast News) - Easyjet: RBC upgrades to outperform with a 1500p target. Restaurant Group: UBS downgrades to neutral with a 305p target. Burberry: Barclays keeps at equal-weight with a 305p target. Smith & Nephew: Berenberg reiterates buy with a target of 1300p and Barclays stays at overweight
Read more9th May 2016 14:31
(ShareCast News) - The FTSE 100 was just above the waterline in afternoon trading on Monday, having retraced earlier gains as oil prices slipped back. Two major players in the travel sector featured highly in the risers, with TUI surging ahead of its half-year results on Wednesday. The tour operato
Read more9th May 2016 10:08
(ShareCast News) - Jefferies upgraded artificial knee and hip maker Smith & Nephew to 'buy' from 'hold' and lifted the price target to 1,375p from 1,044p. The bank pointed out that S&N has rebalanced away from hips and knees and now has leading positions in higher-growth segments. Jefferies said it
Read more5th May 2016 07:32
(ShareCast News) - Artificial knee and hip maker Smith & Nephew posted a 3% rise in first-quarter revenue, as a solid performance in the US was offset by weakness in China. For the quarter ended 2 April, revenue nudged up to $1.14bn from $1.10bn in the same period last year, which was below the $1.1
Read more25th Apr 2016 13:13
(ShareCast News) - Ted Baker: Jefferies upgrades to buy with a 3000p target. Howden Joinery Group: Goldman Sachs upgrades to neutral with a 515p target. Genel Energy: Barclays keeps at overweight with a target price of 115p and Canaccordreiterates speculative buy with a target of 165p. Royal Dutch
Read more12th Apr 2016 19:38
(ShareCast News) - Vesuvius: Jefferies downgrades to sell with a target price of 255p. Ashtead: HSBC downgrades to hold with a target price of 970p. Cairn Energy: Canaccord reiterates hold with a target price of 215p. Just Eat: JP Morgan keeps at outperform with a target of 775p. Vedanta: Jefferi
Read more